Global Drug-Eluting Bioabsorbable Stents Supply, Demand and Key Producers, 2023-2029

Page: 113

Published Date: 25 Jan 2023

Category: Medical Devices & Consumables

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Related Reports
Product Tags

Description

This report studies the global Drug-Eluting Bioabsorbable Stents production, demand, key manufacturers, and key regions.

This report is a detailed and comprehensive analysis of the world market for Drug-Eluting Bioabsorbable Stents, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Drug-Eluting Bioabsorbable Stents that contribute to its increasing demand across many markets.

The global Drug-Eluting Bioabsorbable Stents market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

Highlights and key features of the study
Global Drug-Eluting Bioabsorbable Stents total production and demand, 2018-2029, (K Units)
Global Drug-Eluting Bioabsorbable Stents total production value, 2018-2029, (USD Million)
Global Drug-Eluting Bioabsorbable Stents production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Drug-Eluting Bioabsorbable Stents consumption by region & country, CAGR, 2018-2029 & (K Units)
U.S. VS China: Drug-Eluting Bioabsorbable Stents domestic production, consumption, key domestic manufacturers and share
Global Drug-Eluting Bioabsorbable Stents production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)
Global Drug-Eluting Bioabsorbable Stents production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Drug-Eluting Bioabsorbable Stents production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units)
This reports profiles key players in the global Drug-Eluting Bioabsorbable Stents market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Medtronic, B.Braun Melsungen, Abbott Laboratories, Boston Scientific Corporation, Biosensors International, Terumo Corporation., MicroPort Scientific Corporation, Alvimedica and Biotronik, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Drug-Eluting Bioabsorbable Stents market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (USD/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global Drug-Eluting Bioabsorbable Stents Market, By Region:
    United States
    China
    Europe
    Japan
    South Korea
    ASEAN
    India
    Rest of World

Global Drug-Eluting Bioabsorbable Stents Market, Segmentation by Type
    Serolimus and Paclitaxel Drug-Eluting Stents
    Sirolimus Drug Eluting Stents

Global Drug-Eluting Bioabsorbable Stents Market, Segmentation by Application
    Coronary Artery Diseases
    Peripheral Artery Diseases

Companies Profiled:
    Medtronic
    B.Braun Melsungen
    Abbott Laboratories
    Boston Scientific Corporation
    Biosensors International
    Terumo Corporation.
    MicroPort Scientific Corporation
    Alvimedica
    Biotronik
    Elixir Medical Corporation
    Innovative Health Technologies

Key Questions Answered
1. How big is the global Drug-Eluting Bioabsorbable Stents market?
2. What is the demand of the global Drug-Eluting Bioabsorbable Stents market?
3. What is the year over year growth of the global Drug-Eluting Bioabsorbable Stents market?
4. What is the production and production value of the global Drug-Eluting Bioabsorbable Stents market?
5. Who are the key producers in the global Drug-Eluting Bioabsorbable Stents market?
6. What are the growth factors driving the market demand?

Table of Contents

1 Supply Summary
    1.1 Drug-Eluting Bioabsorbable Stents Introduction
    1.2 World Drug-Eluting Bioabsorbable Stents Supply & Forecast
        1.2.1 World Drug-Eluting Bioabsorbable Stents Production Value (2018 & 2022 & 2029)
        1.2.2 World Drug-Eluting Bioabsorbable Stents Production (2018-2029)
        1.2.3 World Drug-Eluting Bioabsorbable Stents Pricing Trends (2018-2029)
    1.3 World Drug-Eluting Bioabsorbable Stents Production by Region (Based on Production Site)
        1.3.1 World Drug-Eluting Bioabsorbable Stents Production Value by Region (2018-2029)
        1.3.2 World Drug-Eluting Bioabsorbable Stents Production by Region (2018-2029)
        1.3.3 World Drug-Eluting Bioabsorbable Stents Average Price by Region (2018-2029)
        1.3.4 North America Drug-Eluting Bioabsorbable Stents Production (2018-2029)
        1.3.5 Europe Drug-Eluting Bioabsorbable Stents Production (2018-2029)
        1.3.6 China Drug-Eluting Bioabsorbable Stents Production (2018-2029)
        1.3.7 Japan Drug-Eluting Bioabsorbable Stents Production (2018-2029)
    1.4 Market Drivers, Restraints and Trends
        1.4.1 Drug-Eluting Bioabsorbable Stents Market Drivers
        1.4.2 Factors Affecting Demand
        1.4.3 Drug-Eluting Bioabsorbable Stents Major Market Trends
    1.5 Influence of COVID-19 and Russia-Ukraine War
        1.5.1 Influence of COVID-19
        1.5.2 Influence of Russia-Ukraine War

2 Demand Summary
    2.1 World Drug-Eluting Bioabsorbable Stents Demand (2018-2029)
    2.2 World Drug-Eluting Bioabsorbable Stents Consumption by Region
        2.2.1 World Drug-Eluting Bioabsorbable Stents Consumption by Region (2018-2023)
        2.2.2 World Drug-Eluting Bioabsorbable Stents Consumption Forecast by Region (2024-2029)
    2.3 United States Drug-Eluting Bioabsorbable Stents Consumption (2018-2029)
    2.4 China Drug-Eluting Bioabsorbable Stents Consumption (2018-2029)
    2.5 Europe Drug-Eluting Bioabsorbable Stents Consumption (2018-2029)
    2.6 Japan Drug-Eluting Bioabsorbable Stents Consumption (2018-2029)
    2.7 South Korea Drug-Eluting Bioabsorbable Stents Consumption (2018-2029)
    2.8 ASEAN Drug-Eluting Bioabsorbable Stents Consumption (2018-2029)
    2.9 India Drug-Eluting Bioabsorbable Stents Consumption (2018-2029)

3 World Drug-Eluting Bioabsorbable Stents Manufacturers Competitive Analysis
    3.1 World Drug-Eluting Bioabsorbable Stents Production Value by Manufacturer (2018-2023)
    3.2 World Drug-Eluting Bioabsorbable Stents Production by Manufacturer (2018-2023)
    3.3 World Drug-Eluting Bioabsorbable Stents Average Price by Manufacturer (2018-2023)
    3.4 Drug-Eluting Bioabsorbable Stents Company Evaluation Quadrant
    3.5 Industry Rank and Concentration Rate (CR)
        3.5.1 Global Drug-Eluting Bioabsorbable Stents Industry Rank of Major Manufacturers
        3.5.2 Global Concentration Ratios (CR4) for Drug-Eluting Bioabsorbable Stents in 2022
        3.5.3 Global Concentration Ratios (CR8) for Drug-Eluting Bioabsorbable Stents in 2022
    3.6 Drug-Eluting Bioabsorbable Stents Market: Overall Company Footprint Analysis
        3.6.1 Drug-Eluting Bioabsorbable Stents Market: Region Footprint
        3.6.2 Drug-Eluting Bioabsorbable Stents Market: Company Product Type Footprint
        3.6.3 Drug-Eluting Bioabsorbable Stents Market: Company Product Application Footprint
    3.7 Competitive Environment
        3.7.1 Historical Structure of the Industry
        3.7.2 Barriers of Market Entry
        3.7.3 Factors of Competition
    3.8 New Entrant and Capacity Expansion Plans
    3.9 Mergers, Acquisition, Agreements, and Collaborations

4 United States VS China VS Rest of the World
    4.1 United States VS China: Drug-Eluting Bioabsorbable Stents Production Value Comparison
        4.1.1 United States VS China: Drug-Eluting Bioabsorbable Stents Production Value Comparison (2018 & 2022 & 2029)
        4.1.2 United States VS China: Drug-Eluting Bioabsorbable Stents Production Value Market Share Comparison (2018 & 2022 & 2029)
    4.2 United States VS China: Drug-Eluting Bioabsorbable Stents Production Comparison
        4.2.1 United States VS China: Drug-Eluting Bioabsorbable Stents Production Comparison (2018 & 2022 & 2029)
        4.2.2 United States VS China: Drug-Eluting Bioabsorbable Stents Production Market Share Comparison (2018 & 2022 & 2029)
    4.3 United States VS China: Drug-Eluting Bioabsorbable Stents Consumption Comparison
        4.3.1 United States VS China: Drug-Eluting Bioabsorbable Stents Consumption Comparison (2018 & 2022 & 2029)
        4.3.2 United States VS China: Drug-Eluting Bioabsorbable Stents Consumption Market Share Comparison (2018 & 2022 & 2029)
    4.4 United States Based Drug-Eluting Bioabsorbable Stents Manufacturers and Market Share, 2018-2023
        4.4.1 United States Based Drug-Eluting Bioabsorbable Stents Manufacturers, Headquarters and Production Site (States, Country)
        4.4.2 United States Based Manufacturers Drug-Eluting Bioabsorbable Stents Production Value (2018-2023)
        4.4.3 United States Based Manufacturers Drug-Eluting Bioabsorbable Stents Production (2018-2023)
    4.5 China Based Drug-Eluting Bioabsorbable Stents Manufacturers and Market Share
        4.5.1 China Based Drug-Eluting Bioabsorbable Stents Manufacturers, Headquarters and Production Site (Province, Country)
        4.5.2 China Based Manufacturers Drug-Eluting Bioabsorbable Stents Production Value (2018-2023)
        4.5.3 China Based Manufacturers Drug-Eluting Bioabsorbable Stents Production (2018-2023)
    4.6 Rest of World Based Drug-Eluting Bioabsorbable Stents Manufacturers and Market Share, 2018-2023
        4.6.1 Rest of World Based Drug-Eluting Bioabsorbable Stents Manufacturers, Headquarters and Production Site (State, Country)
        4.6.2 Rest of World Based Manufacturers Drug-Eluting Bioabsorbable Stents Production Value (2018-2023)
        4.6.3 Rest of World Based Manufacturers Drug-Eluting Bioabsorbable Stents Production (2018-2023)

5 Market Analysis by Type
    5.1 World Drug-Eluting Bioabsorbable Stents Market Size Overview by Type: 2018 VS 2022 VS 2029
    5.2 Segment Introduction by Type
        5.2.1 Serolimus and Paclitaxel Drug-Eluting Stents
        5.2.2 Sirolimus Drug Eluting Stents
    5.3 Market Segment by Type
        5.3.1 World Drug-Eluting Bioabsorbable Stents Production by Type (2018-2029)
        5.3.2 World Drug-Eluting Bioabsorbable Stents Production Value by Type (2018-2029)
        5.3.3 World Drug-Eluting Bioabsorbable Stents Average Price by Type (2018-2029)

6 Market Analysis by Application
    6.1 World Drug-Eluting Bioabsorbable Stents Market Size Overview by Application: 2018 VS 2022 VS 2029
    6.2 Segment Introduction by Application
        6.2.1 Coronary Artery Diseases
        6.2.2 Peripheral Artery Diseases
    6.3 Market Segment by Application
        6.3.1 World Drug-Eluting Bioabsorbable Stents Production by Application (2018-2029)
        6.3.2 World Drug-Eluting Bioabsorbable Stents Production Value by Application (2018-2029)
        6.3.3 World Drug-Eluting Bioabsorbable Stents Average Price by Application (2018-2029)

7 Company Profiles
    7.1 Medtronic
        7.1.1 Medtronic Details
        7.1.2 Medtronic Major Business
        7.1.3 Medtronic Drug-Eluting Bioabsorbable Stents Product and Services
        7.1.4 Medtronic Drug-Eluting Bioabsorbable Stents Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.1.5 Medtronic Recent Developments/Updates
        7.1.6 Medtronic Competitive Strengths & Weaknesses
    7.2 B.Braun Melsungen
        7.2.1 B.Braun Melsungen Details
        7.2.2 B.Braun Melsungen Major Business
        7.2.3 B.Braun Melsungen Drug-Eluting Bioabsorbable Stents Product and Services
        7.2.4 B.Braun Melsungen Drug-Eluting Bioabsorbable Stents Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.2.5 B.Braun Melsungen Recent Developments/Updates
        7.2.6 B.Braun Melsungen Competitive Strengths & Weaknesses
    7.3 Abbott Laboratories
        7.3.1 Abbott Laboratories Details
        7.3.2 Abbott Laboratories Major Business
        7.3.3 Abbott Laboratories Drug-Eluting Bioabsorbable Stents Product and Services
        7.3.4 Abbott Laboratories Drug-Eluting Bioabsorbable Stents Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.3.5 Abbott Laboratories Recent Developments/Updates
        7.3.6 Abbott Laboratories Competitive Strengths & Weaknesses
    7.4 Boston Scientific Corporation
        7.4.1 Boston Scientific Corporation Details
        7.4.2 Boston Scientific Corporation Major Business
        7.4.3 Boston Scientific Corporation Drug-Eluting Bioabsorbable Stents Product and Services
        7.4.4 Boston Scientific Corporation Drug-Eluting Bioabsorbable Stents Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.4.5 Boston Scientific Corporation Recent Developments/Updates
        7.4.6 Boston Scientific Corporation Competitive Strengths & Weaknesses
    7.5 Biosensors International
        7.5.1 Biosensors International Details
        7.5.2 Biosensors International Major Business
        7.5.3 Biosensors International Drug-Eluting Bioabsorbable Stents Product and Services
        7.5.4 Biosensors International Drug-Eluting Bioabsorbable Stents Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.5.5 Biosensors International Recent Developments/Updates
        7.5.6 Biosensors International Competitive Strengths & Weaknesses
    7.6 Terumo Corporation.
        7.6.1 Terumo Corporation. Details
        7.6.2 Terumo Corporation. Major Business
        7.6.3 Terumo Corporation. Drug-Eluting Bioabsorbable Stents Product and Services
        7.6.4 Terumo Corporation. Drug-Eluting Bioabsorbable Stents Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.6.5 Terumo Corporation. Recent Developments/Updates
        7.6.6 Terumo Corporation. Competitive Strengths & Weaknesses
    7.7 MicroPort Scientific Corporation
        7.7.1 MicroPort Scientific Corporation Details
        7.7.2 MicroPort Scientific Corporation Major Business
        7.7.3 MicroPort Scientific Corporation Drug-Eluting Bioabsorbable Stents Product and Services
        7.7.4 MicroPort Scientific Corporation Drug-Eluting Bioabsorbable Stents Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.7.5 MicroPort Scientific Corporation Recent Developments/Updates
        7.7.6 MicroPort Scientific Corporation Competitive Strengths & Weaknesses
    7.8 Alvimedica
        7.8.1 Alvimedica Details
        7.8.2 Alvimedica Major Business
        7.8.3 Alvimedica Drug-Eluting Bioabsorbable Stents Product and Services
        7.8.4 Alvimedica Drug-Eluting Bioabsorbable Stents Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.8.5 Alvimedica Recent Developments/Updates
        7.8.6 Alvimedica Competitive Strengths & Weaknesses
    7.9 Biotronik
        7.9.1 Biotronik Details
        7.9.2 Biotronik Major Business
        7.9.3 Biotronik Drug-Eluting Bioabsorbable Stents Product and Services
        7.9.4 Biotronik Drug-Eluting Bioabsorbable Stents Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.9.5 Biotronik Recent Developments/Updates
        7.9.6 Biotronik Competitive Strengths & Weaknesses
    7.10 Elixir Medical Corporation
        7.10.1 Elixir Medical Corporation Details
        7.10.2 Elixir Medical Corporation Major Business
        7.10.3 Elixir Medical Corporation Drug-Eluting Bioabsorbable Stents Product and Services
        7.10.4 Elixir Medical Corporation Drug-Eluting Bioabsorbable Stents Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.10.5 Elixir Medical Corporation Recent Developments/Updates
        7.10.6 Elixir Medical Corporation Competitive Strengths & Weaknesses
    7.11 Innovative Health Technologies
        7.11.1 Innovative Health Technologies Details
        7.11.2 Innovative Health Technologies Major Business
        7.11.3 Innovative Health Technologies Drug-Eluting Bioabsorbable Stents Product and Services
        7.11.4 Innovative Health Technologies Drug-Eluting Bioabsorbable Stents Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.11.5 Innovative Health Technologies Recent Developments/Updates
        7.11.6 Innovative Health Technologies Competitive Strengths & Weaknesses

8 Industry Chain Analysis
    8.1 Drug-Eluting Bioabsorbable Stents Industry Chain
    8.2 Drug-Eluting Bioabsorbable Stents Upstream Analysis
        8.2.1 Drug-Eluting Bioabsorbable Stents Core Raw Materials
        8.2.2 Main Manufacturers of Drug-Eluting Bioabsorbable Stents Core Raw Materials
    8.3 Midstream Analysis
    8.4 Downstream Analysis
    8.5 Drug-Eluting Bioabsorbable Stents Production Mode
    8.6 Drug-Eluting Bioabsorbable Stents Procurement Model
    8.7 Drug-Eluting Bioabsorbable Stents Industry Sales Model and Sales Channels
        8.7.1 Drug-Eluting Bioabsorbable Stents Sales Model
        8.7.2 Drug-Eluting Bioabsorbable Stents Typical Customers

9 Research Findings and Conclusion

10 Appendix
    10.1 Methodology
    10.2 Research Process and Data Source
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. World Drug-Eluting Bioabsorbable Stents Production Value by Region (2018, 2022 and 2029) & (USD Million)
    Table 2. World Drug-Eluting Bioabsorbable Stents Production Value by Region (2018-2023) & (USD Million)
    Table 3. World Drug-Eluting Bioabsorbable Stents Production Value by Region (2024-2029) & (USD Million)
    Table 4. World Drug-Eluting Bioabsorbable Stents Production Value Market Share by Region (2018-2023)
    Table 5. World Drug-Eluting Bioabsorbable Stents Production Value Market Share by Region (2024-2029)
    Table 6. World Drug-Eluting Bioabsorbable Stents Production by Region (2018-2023) & (K Units)
    Table 7. World Drug-Eluting Bioabsorbable Stents Production by Region (2024-2029) & (K Units)
    Table 8. World Drug-Eluting Bioabsorbable Stents Production Market Share by Region (2018-2023)
    Table 9. World Drug-Eluting Bioabsorbable Stents Production Market Share by Region (2024-2029)
    Table 10. World Drug-Eluting Bioabsorbable Stents Average Price by Region (2018-2023) & (USD/Unit)
    Table 11. World Drug-Eluting Bioabsorbable Stents Average Price by Region (2024-2029) & (USD/Unit)
    Table 12. Drug-Eluting Bioabsorbable Stents Major Market Trends
    Table 13. World Drug-Eluting Bioabsorbable Stents Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Units)
    Table 14. World Drug-Eluting Bioabsorbable Stents Consumption by Region (2018-2023) & (K Units)
    Table 15. World Drug-Eluting Bioabsorbable Stents Consumption Forecast by Region (2024-2029) & (K Units)
    Table 16. World Drug-Eluting Bioabsorbable Stents Production Value by Manufacturer (2018-2023) & (USD Million)
    Table 17. Production Value Market Share of Key Drug-Eluting Bioabsorbable Stents Producers in 2022
    Table 18. World Drug-Eluting Bioabsorbable Stents Production by Manufacturer (2018-2023) & (K Units)
    Table 19. Production Market Share of Key Drug-Eluting Bioabsorbable Stents Producers in 2022
    Table 20. World Drug-Eluting Bioabsorbable Stents Average Price by Manufacturer (2018-2023) & (USD/Unit)
    Table 21. Global Drug-Eluting Bioabsorbable Stents Company Evaluation Quadrant
    Table 22. World Drug-Eluting Bioabsorbable Stents Industry Rank of Major Manufacturers, Based on Production Value in 2022
    Table 23. Head Office and Drug-Eluting Bioabsorbable Stents Production Site of Key Manufacturer
    Table 24. Drug-Eluting Bioabsorbable Stents Market: Company Product Type Footprint
    Table 25. Drug-Eluting Bioabsorbable Stents Market: Company Product Application Footprint
    Table 26. Drug-Eluting Bioabsorbable Stents Competitive Factors
    Table 27. Drug-Eluting Bioabsorbable Stents New Entrant and Capacity Expansion Plans
    Table 28. Drug-Eluting Bioabsorbable Stents Mergers & Acquisitions Activity
    Table 29. United States VS China Drug-Eluting Bioabsorbable Stents Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
    Table 30. United States VS China Drug-Eluting Bioabsorbable Stents Production Comparison, (2018 & 2022 & 2029) & (K Units)
    Table 31. United States VS China Drug-Eluting Bioabsorbable Stents Consumption Comparison, (2018 & 2022 & 2029) & (K Units)
    Table 32. United States Based Drug-Eluting Bioabsorbable Stents Manufacturers, Headquarters and Production Site (States, Country)
    Table 33. United States Based Manufacturers Drug-Eluting Bioabsorbable Stents Production Value, (2018-2023) & (USD Million)
    Table 34. United States Based Manufacturers Drug-Eluting Bioabsorbable Stents Production Value Market Share (2018-2023)
    Table 35. United States Based Manufacturers Drug-Eluting Bioabsorbable Stents Production (2018-2023) & (K Units)
    Table 36. United States Based Manufacturers Drug-Eluting Bioabsorbable Stents Production Market Share (2018-2023)
    Table 37. China Based Drug-Eluting Bioabsorbable Stents Manufacturers, Headquarters and Production Site (Province, Country)
    Table 38. China Based Manufacturers Drug-Eluting Bioabsorbable Stents Production Value, (2018-2023) & (USD Million)
    Table 39. China Based Manufacturers Drug-Eluting Bioabsorbable Stents Production Value Market Share (2018-2023)
    Table 40. China Based Manufacturers Drug-Eluting Bioabsorbable Stents Production (2018-2023) & (K Units)
    Table 41. China Based Manufacturers Drug-Eluting Bioabsorbable Stents Production Market Share (2018-2023)
    Table 42. Rest of World Based Drug-Eluting Bioabsorbable Stents Manufacturers, Headquarters and Production Site (States, Country)
    Table 43. Rest of World Based Manufacturers Drug-Eluting Bioabsorbable Stents Production Value, (2018-2023) & (USD Million)
    Table 44. Rest of World Based Manufacturers Drug-Eluting Bioabsorbable Stents Production Value Market Share (2018-2023)
    Table 45. Rest of World Based Manufacturers Drug-Eluting Bioabsorbable Stents Production (2018-2023) & (K Units)
    Table 46. Rest of World Based Manufacturers Drug-Eluting Bioabsorbable Stents Production Market Share (2018-2023)
    Table 47. World Drug-Eluting Bioabsorbable Stents Production Value by Type, (USD Million), 2018 & 2022 & 2029
    Table 48. World Drug-Eluting Bioabsorbable Stents Production by Type (2018-2023) & (K Units)
    Table 49. World Drug-Eluting Bioabsorbable Stents Production by Type (2024-2029) & (K Units)
    Table 50. World Drug-Eluting Bioabsorbable Stents Production Value by Type (2018-2023) & (USD Million)
    Table 51. World Drug-Eluting Bioabsorbable Stents Production Value by Type (2024-2029) & (USD Million)
    Table 52. World Drug-Eluting Bioabsorbable Stents Average Price by Type (2018-2023) & (USD/Unit)
    Table 53. World Drug-Eluting Bioabsorbable Stents Average Price by Type (2024-2029) & (USD/Unit)
    Table 54. World Drug-Eluting Bioabsorbable Stents Production Value by Application, (USD Million), 2018 & 2022 & 2029
    Table 55. World Drug-Eluting Bioabsorbable Stents Production by Application (2018-2023) & (K Units)
    Table 56. World Drug-Eluting Bioabsorbable Stents Production by Application (2024-2029) & (K Units)
    Table 57. World Drug-Eluting Bioabsorbable Stents Production Value by Application (2018-2023) & (USD Million)
    Table 58. World Drug-Eluting Bioabsorbable Stents Production Value by Application (2024-2029) & (USD Million)
    Table 59. World Drug-Eluting Bioabsorbable Stents Average Price by Application (2018-2023) & (USD/Unit)
    Table 60. World Drug-Eluting Bioabsorbable Stents Average Price by Application (2024-2029) & (USD/Unit)
    Table 61. Medtronic Basic Information, Manufacturing Base and Competitors
    Table 62. Medtronic Major Business
    Table 63. Medtronic Drug-Eluting Bioabsorbable Stents Product and Services
    Table 64. Medtronic Drug-Eluting Bioabsorbable Stents Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 65. Medtronic Recent Developments/Updates
    Table 66. Medtronic Competitive Strengths & Weaknesses
    Table 67. B.Braun Melsungen Basic Information, Manufacturing Base and Competitors
    Table 68. B.Braun Melsungen Major Business
    Table 69. B.Braun Melsungen Drug-Eluting Bioabsorbable Stents Product and Services
    Table 70. B.Braun Melsungen Drug-Eluting Bioabsorbable Stents Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 71. B.Braun Melsungen Recent Developments/Updates
    Table 72. B.Braun Melsungen Competitive Strengths & Weaknesses
    Table 73. Abbott Laboratories Basic Information, Manufacturing Base and Competitors
    Table 74. Abbott Laboratories Major Business
    Table 75. Abbott Laboratories Drug-Eluting Bioabsorbable Stents Product and Services
    Table 76. Abbott Laboratories Drug-Eluting Bioabsorbable Stents Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 77. Abbott Laboratories Recent Developments/Updates
    Table 78. Abbott Laboratories Competitive Strengths & Weaknesses
    Table 79. Boston Scientific Corporation Basic Information, Manufacturing Base and Competitors
    Table 80. Boston Scientific Corporation Major Business
    Table 81. Boston Scientific Corporation Drug-Eluting Bioabsorbable Stents Product and Services
    Table 82. Boston Scientific Corporation Drug-Eluting Bioabsorbable Stents Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 83. Boston Scientific Corporation Recent Developments/Updates
    Table 84. Boston Scientific Corporation Competitive Strengths & Weaknesses
    Table 85. Biosensors International Basic Information, Manufacturing Base and Competitors
    Table 86. Biosensors International Major Business
    Table 87. Biosensors International Drug-Eluting Bioabsorbable Stents Product and Services
    Table 88. Biosensors International Drug-Eluting Bioabsorbable Stents Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 89. Biosensors International Recent Developments/Updates
    Table 90. Biosensors International Competitive Strengths & Weaknesses
    Table 91. Terumo Corporation. Basic Information, Manufacturing Base and Competitors
    Table 92. Terumo Corporation. Major Business
    Table 93. Terumo Corporation. Drug-Eluting Bioabsorbable Stents Product and Services
    Table 94. Terumo Corporation. Drug-Eluting Bioabsorbable Stents Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 95. Terumo Corporation. Recent Developments/Updates
    Table 96. Terumo Corporation. Competitive Strengths & Weaknesses
    Table 97. MicroPort Scientific Corporation Basic Information, Manufacturing Base and Competitors
    Table 98. MicroPort Scientific Corporation Major Business
    Table 99. MicroPort Scientific Corporation Drug-Eluting Bioabsorbable Stents Product and Services
    Table 100. MicroPort Scientific Corporation Drug-Eluting Bioabsorbable Stents Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 101. MicroPort Scientific Corporation Recent Developments/Updates
    Table 102. MicroPort Scientific Corporation Competitive Strengths & Weaknesses
    Table 103. Alvimedica Basic Information, Manufacturing Base and Competitors
    Table 104. Alvimedica Major Business
    Table 105. Alvimedica Drug-Eluting Bioabsorbable Stents Product and Services
    Table 106. Alvimedica Drug-Eluting Bioabsorbable Stents Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 107. Alvimedica Recent Developments/Updates
    Table 108. Alvimedica Competitive Strengths & Weaknesses
    Table 109. Biotronik Basic Information, Manufacturing Base and Competitors
    Table 110. Biotronik Major Business
    Table 111. Biotronik Drug-Eluting Bioabsorbable Stents Product and Services
    Table 112. Biotronik Drug-Eluting Bioabsorbable Stents Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 113. Biotronik Recent Developments/Updates
    Table 114. Biotronik Competitive Strengths & Weaknesses
    Table 115. Elixir Medical Corporation Basic Information, Manufacturing Base and Competitors
    Table 116. Elixir Medical Corporation Major Business
    Table 117. Elixir Medical Corporation Drug-Eluting Bioabsorbable Stents Product and Services
    Table 118. Elixir Medical Corporation Drug-Eluting Bioabsorbable Stents Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 119. Elixir Medical Corporation Recent Developments/Updates
    Table 120. Innovative Health Technologies Basic Information, Manufacturing Base and Competitors
    Table 121. Innovative Health Technologies Major Business
    Table 122. Innovative Health Technologies Drug-Eluting Bioabsorbable Stents Product and Services
    Table 123. Innovative Health Technologies Drug-Eluting Bioabsorbable Stents Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 124. Global Key Players of Drug-Eluting Bioabsorbable Stents Upstream (Raw Materials)
    Table 125. Drug-Eluting Bioabsorbable Stents Typical Customers
    Table 126. Drug-Eluting Bioabsorbable Stents Typical Distributors
List of Figure
    Figure 1. Drug-Eluting Bioabsorbable Stents Picture
    Figure 2. World Drug-Eluting Bioabsorbable Stents Production Value: 2018 & 2022 & 2029, (USD Million)
    Figure 3. World Drug-Eluting Bioabsorbable Stents Production Value and Forecast (2018-2029) & (USD Million)
    Figure 4. World Drug-Eluting Bioabsorbable Stents Production (2018-2029) & (K Units)
    Figure 5. World Drug-Eluting Bioabsorbable Stents Average Price (2018-2029) & (USD/Unit)
    Figure 6. World Drug-Eluting Bioabsorbable Stents Production Value Market Share by Region (2018-2029)
    Figure 7. World Drug-Eluting Bioabsorbable Stents Production Market Share by Region (2018-2029)
    Figure 8. North America Drug-Eluting Bioabsorbable Stents Production (2018-2029) & (K Units)
    Figure 9. Europe Drug-Eluting Bioabsorbable Stents Production (2018-2029) & (K Units)
    Figure 10. China Drug-Eluting Bioabsorbable Stents Production (2018-2029) & (K Units)
    Figure 11. Japan Drug-Eluting Bioabsorbable Stents Production (2018-2029) & (K Units)
    Figure 12. Drug-Eluting Bioabsorbable Stents Market Drivers
    Figure 13. Factors Affecting Demand
    Figure 14. World Drug-Eluting Bioabsorbable Stents Consumption (2018-2029) & (K Units)
    Figure 15. World Drug-Eluting Bioabsorbable Stents Consumption Market Share by Region (2018-2029)
    Figure 16. United States Drug-Eluting Bioabsorbable Stents Consumption (2018-2029) & (K Units)
    Figure 17. China Drug-Eluting Bioabsorbable Stents Consumption (2018-2029) & (K Units)
    Figure 18. Europe Drug-Eluting Bioabsorbable Stents Consumption (2018-2029) & (K Units)
    Figure 19. Japan Drug-Eluting Bioabsorbable Stents Consumption (2018-2029) & (K Units)
    Figure 20. South Korea Drug-Eluting Bioabsorbable Stents Consumption (2018-2029) & (K Units)
    Figure 21. ASEAN Drug-Eluting Bioabsorbable Stents Consumption (2018-2029) & (K Units)
    Figure 22. India Drug-Eluting Bioabsorbable Stents Consumption (2018-2029) & (K Units)
    Figure 23. Producer Shipments of Drug-Eluting Bioabsorbable Stents by Manufacturer Revenue ($MM) and Market Share (%): 2022
    Figure 24. Global Four-firm Concentration Ratios (CR4) for Drug-Eluting Bioabsorbable Stents Markets in 2022
    Figure 25. Global Four-firm Concentration Ratios (CR8) for Drug-Eluting Bioabsorbable Stents Markets in 2022
    Figure 26. United States VS China: Drug-Eluting Bioabsorbable Stents Production Value Market Share Comparison (2018 & 2022 & 2029)
    Figure 27. United States VS China: Drug-Eluting Bioabsorbable Stents Production Market Share Comparison (2018 & 2022 & 2029)
    Figure 28. United States VS China: Drug-Eluting Bioabsorbable Stents Consumption Market Share Comparison (2018 & 2022 & 2029)
    Figure 29. United States Based Manufacturers Drug-Eluting Bioabsorbable Stents Production Market Share 2022
    Figure 30. China Based Manufacturers Drug-Eluting Bioabsorbable Stents Production Market Share 2022
    Figure 31. Rest of World Based Manufacturers Drug-Eluting Bioabsorbable Stents Production Market Share 2022
    Figure 32. World Drug-Eluting Bioabsorbable Stents Production Value by Type, (USD Million), 2018 & 2022 & 2029
    Figure 33. World Drug-Eluting Bioabsorbable Stents Production Value Market Share by Type in 2022
    Figure 34. Serolimus and Paclitaxel Drug-Eluting Stents
    Figure 35. Sirolimus Drug Eluting Stents
    Figure 36. World Drug-Eluting Bioabsorbable Stents Production Market Share by Type (2018-2029)
    Figure 37. World Drug-Eluting Bioabsorbable Stents Production Value Market Share by Type (2018-2029)
    Figure 38. World Drug-Eluting Bioabsorbable Stents Average Price by Type (2018-2029) & (USD/Unit)
    Figure 39. World Drug-Eluting Bioabsorbable Stents Production Value by Application, (USD Million), 2018 & 2022 & 2029
    Figure 40. World Drug-Eluting Bioabsorbable Stents Production Value Market Share by Application in 2022
    Figure 41. Coronary Artery Diseases
    Figure 42. Peripheral Artery Diseases
    Figure 43. World Drug-Eluting Bioabsorbable Stents Production Market Share by Application (2018-2029)
    Figure 44. World Drug-Eluting Bioabsorbable Stents Production Value Market Share by Application (2018-2029)
    Figure 45. World Drug-Eluting Bioabsorbable Stents Average Price by Application (2018-2029) & (USD/Unit)
    Figure 46. Drug-Eluting Bioabsorbable Stents Industry Chain
    Figure 47. Drug-Eluting Bioabsorbable Stents Procurement Model
    Figure 48. Drug-Eluting Bioabsorbable Stents Sales Model
    Figure 49. Drug-Eluting Bioabsorbable Stents Sales Channels, Direct Sales, and Distribution
    Figure 50. Methodology
    Figure 51. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Related Reports

Global Drug-Eluting Bioabsorbable Stents Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Global Drug-Eluting Bioabsorbable Stents Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

date 02 Jan 2024

date Medical Devices & Consumables

According to our (Global Info Research) latest study, the global Drug-Eluting Bioabsorbable Stents market size was valued at USD 920.1 million in 2023 and is forecast to a readjusted size of USD 1236 million by 2030 with a CAGR of 4.3% during review period.

Product Tags

Drug-Eluting Bioabsorbable Stents

Blood Plasma Refrigerator

ENT Camera System

Medical Repair Titanium Mesh

Purchase Options

Single User License

USD4480.00

Multi User License

USD6720.00

Corporate Users License

USD8960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>